Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)

L. Jehn (Essen, Germany), J. Wälscher (Essen, Germany), T. Wessendorf (Essen, Germany), E. Livingstone (Essen, Germany), L. Zimmer (Essen, Germany), M. Metzenmacher (Essen, Germany), W. Eberhardt (Essen, Germany), D. Theegarten (Essen, Germany), F. Bonella (Essen, Germany)

Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Session: Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Session type: Oral Presentation
Number: 4240

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Jehn (Essen, Germany), J. Wälscher (Essen, Germany), T. Wessendorf (Essen, Germany), E. Livingstone (Essen, Germany), L. Zimmer (Essen, Germany), M. Metzenmacher (Essen, Germany), W. Eberhardt (Essen, Germany), D. Theegarten (Essen, Germany), F. Bonella (Essen, Germany). Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP). 4240

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002

Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006

Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003

Bronchoalveolar lavage fluid protein concentrations define phenotipically distinct populations within group of patients with hypersensitivity pneumonitis (HP)
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004

Bronchoalveolar lavage (BAL) to monitor disease progression
Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis
Year: 2012

Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF)
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006


The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Bronchoalveolar lavage fluid (BALF) phospholipids (PL) and tumor necrosis factor-α (TNF-α) produced by alveolar macrophages (AM) can be used for predicting the course of sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002

Which BAL fluid (BALF) analyses are clinically useful in immunocomptent children?
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013

Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016


Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001

Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis
Source: Eur Respir J 2003; 21: 144-148
Year: 2003